Category archives for: Business

CEO and Chair of the Board of Seer, Inc. (NASDAQ:SEER), Farokhzad Omid, sells 354,741 shares worth $22,756,635

According to Seer, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:45 PM, company CEO and Chair of the Board, Farokhzad Omid disclosed selling 354,741 shares at a cost of $64.15. At the time of this transaction (Feb 17), this trade was worth $22,756,635 […]

Director of Bjs Restaurants Inc (NASDAQ:BJRI), Bouts Larry D, sells 5,882 shares worth $312,393

According to Bjs Restaurants Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:44 PM, company Director, Bouts Larry D disclosed selling 5,882 shares at a cost of $53.11. At the time of this transaction (Feb 19), this trade was worth $312,393 in total. As […]

Chief Financial Officer of Phreesia, Inc. (NYSE:PHR), Altier Thomas, sells 904 shares worth $65,834

According to Phreesia, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:37 PM, company Chief Financial Officer, Altier Thomas disclosed selling 904 shares at a cost of $72.83. At the time of this transaction (Feb 19), this trade was worth $65,834 in total. As […]

Chief Financial Officer of Phreesia, Inc. (NYSE:PHR), Altier Thomas, sells 76,272 shares worth $5,488,349

According to Phreesia, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:37 PM, company Chief Financial Officer, Altier Thomas disclosed selling 76,272 shares at a cost of $71.96. At the time of this transaction (Feb 18), this trade was worth $5,488,349 in total. As […]

Chief Medical Officer of Bioxcel Therapeutics, Inc. (NASDAQ:BTAI), O’Neill Vincent, sells 25,000 shares worth $1,389,459

According to Bioxcel Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:35 PM, company Chief Medical Officer, O’Neill Vincent disclosed selling 25,000 shares at a cost of $55.58. At the time of this transaction (Feb 17), this trade was worth $1,389,459 in total. […]

Director of Jfrog Ltd (NASDAQ:FROG), Sela Yossi, sells 76,683 shares worth $5,229,827

According to Jfrog Ltd’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:31 PM, company Director, Sela Yossi disclosed selling 76,683 shares at a cost of $68.20. At the time of this transaction (Feb 19), this trade was worth $5,229,827 in total. As of Feb […]

Director of Jfrog Ltd (NASDAQ:FROG), Sela Yossi, sells 80,000 shares worth $5,264,429

According to Jfrog Ltd’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:31 PM, company Director, Sela Yossi disclosed selling 80,000 shares at a cost of $65.81. At the time of this transaction (Feb 18), this trade was worth $5,264,429 in total. As of Feb […]

Director of Jfrog Ltd (NASDAQ:FROG), Sela Yossi, sells 160,000 shares worth $10,523,570

According to Jfrog Ltd’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:31 PM, company Director, Sela Yossi disclosed selling 160,000 shares at a cost of $65.77. At the time of this transaction (Feb 17), this trade was worth $10,523,570 in total. As of Feb […]

Director of Zillow Group, Inc. (NASDAQ:Z), Stephenson Gordon Sheridan, sells 11,004 shares worth $1,989,095

According to Zillow Group, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:28 PM, company Director, Stephenson Gordon Sheridan disclosed selling 11,004 shares at a cost of $180.76. At the time of this transaction (Feb 18), this trade was worth $1,989,095 in total. As […]

Chief Medical Officer of Kymera Therapeutics, Inc. (NASDAQ:KYMR), Gollob Jared, sells 8,887 shares worth $489,559

According to Kymera Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 07:27 PM, company Chief Medical Officer, Gollob Jared disclosed selling 8,887 shares at a cost of $55.09. At the time of this transaction (Feb 19), this trade was worth $489,559 in total. […]

Featured Press Releases

Photo Gallery

Log in